Pfizer Inc. and partner BioNTech completed the filing with the U.S. drugs regulator seeking authorization for their COVID-19 vaccine in children under 5 years of age.
https://www.pharmalive.com/wp-content/uploads/2022/06/ReutersPfizerCOVIDvaccine6-2-2022.webp7761200Reuters Healthhttps://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.pngReuters Health2022-06-02 08:30:242022-06-02 11:41:29Pfizer seeks U.S. authorization of COVID vaccine for young children
